Harmonized Index of Consumer Prices: Pharmaceutical Products for Slovakia
CP0611SKM086NEST • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
132.03
Year-over-Year Change
-1.76%
Date Range
1/1/1996 - 7/1/2025
Summary
The Harmonized Index of Consumer Prices (HICP) for Pharmaceutical Products in Slovakia tracks changes in the prices paid by consumers for pharmaceutical goods and services. This key economic indicator provides insights into inflation and consumer spending patterns within the pharmaceutical market.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The HICP for Pharmaceutical Products in Slovakia is a component of the broader HICP, which measures the change over time in the prices of consumer goods and services acquired by households. This sub-index focuses specifically on the prices paid for pharmaceuticals, a critical sector for healthcare and household expenditures.
Methodology
The data is collected through surveys of retail prices paid by consumers for a representative basket of pharmaceutical products.
Historical Context
The HICP for Pharmaceutical Products is used by policymakers, economists, and market analysts to assess inflationary pressures and consumer behavior within the pharmaceutical industry.
Key Facts
- The HICP for Pharmaceutical Products in Slovakia has a base year of 2015.
- Pharmaceuticals account for a significant portion of household budgets in Slovakia.
- Monitoring this index can provide insights into the affordability of healthcare in the country.
FAQs
Q: What does this economic trend measure?
A: The Harmonized Index of Consumer Prices (HICP) for Pharmaceutical Products in Slovakia tracks changes in the prices paid by consumers for pharmaceutical goods and services.
Q: Why is this trend relevant for users or analysts?
A: This index provides insights into inflationary pressures and consumer spending patterns within the pharmaceutical market, which is a critical sector for healthcare and household budgets.
Q: How is this data collected or calculated?
A: The data is collected through surveys of retail prices paid by consumers for a representative basket of pharmaceutical products.
Q: How is this trend used in economic policy?
A: The HICP for Pharmaceutical Products is used by policymakers, economists, and market analysts to assess inflationary pressures and consumer behavior within the pharmaceutical industry.
Q: Are there update delays or limitations?
A: The data is published regularly by the U.S. Federal Reserve and may be subject to minor update delays or revisions.
Related Trends
Infra-Annual Labor Statistics: Employment Rate Male: From 15 to 74 Years for Slovak Republic
LREM74MASKQ156S
National Accounts: GDP by Expenditure: Current Prices: Less: Imports of Goods and Services for Slovak Republic
SVKIMPORTADSMEI
International Merchandise Trade Statistics: Exports: Commodities for Slovak Republic
XTEXVA01SKQ657S
Infra-Annual Labor Statistics: Unemployment Rate Total: From 15 to 64 Years for Slovak Republic
LRUN64TTSKQ156S
Infra-Annual Labor Statistics: Labor Force Total: From 15 to 24 Years for Slovak Republic
LFAC24TTSKQ647N
Amount Outstanding of Total Debt Securities for All Issuers, All Maturities, Residence of Issuer in Slovakia
TDSAMRIAOAISK
Citation
U.S. Federal Reserve, Harmonized Index of Consumer Prices: Pharmaceutical Products for Slovakia (CP0611SKM086NEST), retrieved from FRED.